Investing Profile

Mike Ross

InvestorVC
Managing Partner at SV Health Investors
svhealthinvestors.comSan Mateo, California
Photo of Mike Ross, Managing Partner at SV Health Investors
cb
SV Health Investors Managing Partner
$100K - $5.0M
$1.5M
15
£200M
CompanyStageDateRound SizeTotal Raised
Eyebiotech
Series ANov 2023$65M
Series AFeb 2022$65M
SeedAug 2021
$130M
Co-investors: Bernard Davitian (Omega Funds), Kate Bingham (SV Health Investors)
Therini Bio
Series AApr 2023$36M
SeedMay 2021$17M
SeedJul 2019$9M
$62M
Co-investors: Jim Trenkle (Sanofi Ventures), Laurence Barker (SV Health Investors), Houman Ashrafian (SV Health Investors), Pascal Levensohn (Dolby Family Ventures)
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
Series ASep 2018$30M
$330M
Co-investors: Nancy Hong (RiverVest), Jack Kenney (SV Health Investors), Peter Dudek (MRL Ventures Fund), Andrew Hack (Bain Capital Life Sciences), Jayson Punwani (Abingworth)
Thesan Pharmaceuticals
Series BJan 2016
Series BFeb 2014$49M
$65M
Co-investors: Giovanni Ferrara
Avitide
Series CAug 2015$8M
Series AMar 2013$1M
$21M
Co-investors: Phil Ferneau (Borealis Ventures)
Arsanis
Series AFeb 2011$10M
$76M
Co-investors: Carl Gordon (OrbiMed), Terry McGuire (Polaris Partners), Amy Schulman (Polaris Partners)
Archemix
Series AAug 2002$52M
$100M
Co-investors: Peter Barrett (Atlas Venture)